A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
City of Hope Medical Center
Second Affiliated Hospital of Soochow University
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Radiation Therapy Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
St. Jude Children's Research Hospital
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Northwestern University
M.D. Anderson Cancer Center
Children's Hospital of Philadelphia
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
AIDS Malignancy Consortium
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Alliance for Clinical Trials in Oncology
Massachusetts General Hospital
Trans Tasman Radiation Oncology Group
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Affiliated Hospital to Academy of Military Medical Sciences
M.D. Anderson Cancer Center
University of Miami
Roswell Park Cancer Institute
City of Hope Medical Center
Hoffmann-La Roche